BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dossena M, Ferrario A, Lopardo V, Ciaglia E, Puca AA. New Insights for BPIFB4 in Cardiovascular Therapy. Int J Mol Sci 2020;21:E7163. [PMID: 32998388 DOI: 10.3390/ijms21197163] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Puca AA, Lopardo V, Montella F, Di Pietro P, Cesselli D, Rolle IG, Bulfoni M, Di Sarno V, Iaconetta G, Campiglia P, Vecchione C, Beltrami AP, Ciaglia E. The Longevity-Associated Variant of BPIFB4 Reduces Senescence in Glioma Cells and in Patients’ Lymphocytes Favoring Chemotherapy Efficacy. Cells 2022;11:294. [DOI: 10.3390/cells11020294] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ciaglia E, Lopardo V, Montella F, Sellitto C, Manzo V, De Bellis E, Iannaccone T, Franci G, Zannella C, Pagliano P, Di Pietro P, Carrizzo A, Vecchione C, Conti V, Filippelli A, Puca AA. BPIFB4 Circulating Levels and Its Prognostic Relevance in COVID-19. J Gerontol A Biol Sci Med Sci 2021:glab208. [PMID: 34396395 DOI: 10.1093/gerona/glab208] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
3 Lee S, Bartlett B, Dwivedi G. Adaptive Immune Responses in Human Atherosclerosis. Int J Mol Sci 2020;21:E9322. [PMID: 33297441 DOI: 10.3390/ijms21239322] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]